Microsphere-based antibody assays for human parvovirus B19V, CMV and T. gondii.

PubWeight™: 0.83‹?›

🔗 View Article (PMID 26746194)

Published in BMC Infect Dis on January 08, 2016

Authors

Yilin Wang1, Lea Hedman2, Maria F Perdomo3, Amal Elfaitouri4, Agnes Bölin-Wiener5, Arun Kumar6,7, Maija Lappalainen8,9, Maria Söderlund-Venermo10, Jonas Blomberg11, Klaus Hedman12,13

Author Affiliations

1: Virology, University of Helsinki, Haartmaninkatu 3, FI-00290, Helsinki, Finland. yilin.wang@helsinki.fi.
2: Helsinki University Hospital, Helsinki, Finland. lea.hedman@helsinki.fi.
3: Virology, University of Helsinki, Haartmaninkatu 3, FI-00290, Helsinki, Finland. maria.perdomo@helsinki.fi.
4: Section of Clinical Virology, Department of Medical Sciences, Uppsala University and Uppsala University Hospital, Uppsala, Sweden. amalelfaitouri@hotmail.com.
5: Section of Clinical Virology, Department of Medical Sciences, Uppsala University and Uppsala University Hospital, Uppsala, Sweden. agneswiener@gmail.com.
6: Virology, University of Helsinki, Haartmaninkatu 3, FI-00290, Helsinki, Finland. arun.q.kumar@gsk.com.
7: Present address: T-Cell Platform, Translational Medicine, Novartis Vaccines (a GSK company), Siena, Italy. arun.q.kumar@gsk.com.
8: Virology, University of Helsinki, Haartmaninkatu 3, FI-00290, Helsinki, Finland. Maija.Lappalainen@hus.fi.
9: Helsinki University Hospital, Helsinki, Finland. Maija.Lappalainen@hus.fi.
10: Virology, University of Helsinki, Haartmaninkatu 3, FI-00290, Helsinki, Finland. Maria.Soderlund-Venermo@helsinki.fi.
11: Section of Clinical Virology, Department of Medical Sciences, Uppsala University and Uppsala University Hospital, Uppsala, Sweden. jonas.blomberg@medsci.uu.se.
12: Virology, University of Helsinki, Haartmaninkatu 3, FI-00290, Helsinki, Finland. Klaus.Hedman@helsinki.fi.
13: Helsinki University Hospital, Helsinki, Finland. Klaus.Hedman@helsinki.fi.

Articles cited by this

Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins. Clin Chem (2005) 4.18

Statistics in medical journals: developments in the 1980s. Stat Med (1991) 2.86

Clinical assessment and improved diagnosis of bocavirus-induced wheezing in children, Finland. Emerg Infect Dis (2009) 1.87

Multiplexed microsphere-based flow cytometric assays. Exp Hematol (2002) 1.70

Development of internal controls for the Luminex instrument as part of a multiplex seven-analyte viral respiratory antibody profile. Clin Diagn Lab Immunol (2002) 1.47

Multiplexed microsphere-based flow cytometric immunoassays for human cytokines. J Immunol Methods (2003) 1.32

Seroepidemiology of the newly found trichodysplasia spinulosa-associated polyomavirus. J Infect Dis (2011) 1.28

Serodiagnosis of primary infections with human parvovirus 4, Finland. Emerg Infect Dis (2011) 1.22

Toxoplasmosis in the fetus and newborn: an update on prevalence, diagnosis and treatment. Expert Rev Anti Infect Ther (2012) 1.15

Human parvovirus B19 infection during pregnancy--value of modern molecular and serological diagnostics. J Clin Virol (2005) 1.12

Acute-phase-specific heptapeptide epitope for diagnosis of parvovirus B19 infection. J Clin Microbiol (1999) 1.09

Epitopes of microbial and human heat shock protein 60 and their recognition in myalgic encephalomyelitis. PLoS One (2013) 1.00

Yield and costs of screening growth-retarded infants for torch infections. Am J Perinatol (2000) 0.89

Diagnosis of human parvovirus B19 infections by detection of epitope-type-specific VP2 IgG. J Med Virol (2001) 0.87

Screening, prevention, and treatment of congenital cytomegalovirus. Obstet Gynecol Clin North Am (2014) 0.83